Postprandial Glycemia After Eating a Pasta Dish Made With Resistant Starch.
NCT ID: NCT05988580
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2023-09-01
2023-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to assess the effect on postprandial glycemia of eating a pasta dish made with resistant starch versus its original version.
For this purpose, a randomized, double blind crossover study has been designed.
Target sample size is 18 subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pasta and Other Durum Wheat-based Products: Effects on Post-prandial Glucose Metabolism
NCT03024983
Comparison of Different Types of Resistant Starch
NCT00930956
Pasta and Couscous Prepared With Durum Wheat Semolina: Effect on Post-prandial Glucose and Insulin Metabolism
NCT03098017
Blood Glucose Response of Processed Starch
NCT06048978
Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults
NCT00687960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Experimental group (pasta dish made with resistant starch).
* Control group (original pasta dish).
Volunteers who wish to participate in the study will be interviewed by phone to verify that they meet the main inclusion criteria. Volunteers who meet the main inclusion criteria will be invited to an information and screening visit to resolve any doubts. Volunteers who agree to participate in the study will sign the informed consent and will be randomly assigned to one of the two arms of the study.
The two visits (clinical investigation days) of the study will take place with the volunteers in a fasting state of 4 hours and separated by at least 1 week washout period. The day before the visit, volunteers won't be able to drink alcohol, drink and eat excessively, and/or sleep few hours. Both visits will consist of eating a pasta dish in a maximum of 15 minutes. Blood samples will be taken before eating and during the 2.5 hours after (30, 60, 90, 120 and 150 minutes), in order to analyze the evolution of blood glucose and insulin levels.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Subjects will consume a pasta dish with 20-22% of resistant starch
Pasta dish with resistant starch
Pasta dish with 20-22% of resistant starch
Original version of pasta dish
Original pasta dish, not reinforced with resistant starch
Control group
Subjects will consume the original version of pasta dish
Pasta dish with resistant starch
Pasta dish with 20-22% of resistant starch
Original version of pasta dish
Original pasta dish, not reinforced with resistant starch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pasta dish with resistant starch
Pasta dish with 20-22% of resistant starch
Original version of pasta dish
Original pasta dish, not reinforced with resistant starch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index: 18.5-29.9 kg/m2
* Volunteers who like and feel good with the ingredients of the dish.
* Good physical and psychological state.
* Volunteers undergoing pharmacological treatment will be maintained if the dose is stable for at least 3 months before the start of the study, excluding treatments that alter gastrointestinal function or glucose metabolism.
* Subjects must be able to understand and be willing to sign the informed consent, and must comply with all the procedures and requirements of the study.
* No weight variations considered relevant (+/- 3kg) in the last 3 months.
Exclusion Criteria
* Subjects who have undergone surgical interventions with permanent sequelae in the digestive system (for example, gastroduodenostomy).
* Subjects with a high alcohol intake, more than 14 units (women) and 20 units (men).
* Women who are breastfeeding or pregnant.
* Subjects with liver disease.
* Subjects with some type of cancer or undergoing treatment for it, or who have not had a period of at least 5 years since its eradication.
* Subjects with allergies to any component of the product under study or any other food that interferes and makes it difficult to monitor the study.
* Subjects who present some type of cognitive and/or psychic impairment.
* Subjects in whom poor collaboration is expected or who, in the opinion of the investigator, have difficulties in following the study procedures.
* Subjects who work the night shift.
* Subjects who follow some type of supplementation that interferes with the study.
* Subjects who are immersed in some treatment for weight loss.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinica Universidad de Navarra, Universidad de Navarra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fermín I Milagro Yoldi, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Navarra
Idoia Ibero-Baraibar, PhD
Role: STUDY_CHAIR
University of Navarra
Carlos J González-Navarro, PhD
Role: STUDY_CHAIR
University of Navarra
Miguel López-Yoldi, PhD
Role: STUDY_CHAIR
University of Navarra
Salomé Pérez Diez
Role: STUDY_CHAIR
University of Navarra
Blanca Martínez de Morentin
Role: STUDY_CHAIR
University of Navarra
José I Riezu-Boj, PhD
Role: STUDY_CHAIR
University of Navarra
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Nutrition Research
Pamplona, Navarre, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALISSEC 2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.